Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.

Choong NW, Mauer AM, Hoffman PC, Rudin CM, Winegarden JD, Villano JL, Kozloff M, Wade JL, Sciortino DF, Szeto L, Vokes EE. Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer. J Thorac Oncol. 2006 Mar; 1(3):245-51.

View in: PubMed